- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
DOXIPROCT - - 30g
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C05BX51 | B | Calcium dobesilate - 4%, Lidocaine HCl - 2% | 7080 | 24718/79 | DOXIPROCT | 30g | Ointment | Topical | UPO S.A.L. | OM Pharma | Switzerland | 610,104 L.L | 23.08 | A1 | 2/5/2024 | 0 |